
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Richard Migliori, MD, UnitedHealth's chief medical officer, returns to the Pharmacy Podcast Show to share his vision of patient-centered technologies, health care policy, and pharmacy's critical role in patient care.
Richard Migliori, MD, UnitedHealth's chief medical officer, returns to the Pharmacy Podcast Show to share his vision of patient-centered technologies, health care policy, and pharmacy’s critical role in patient care.






